Back to Journals » OncoTargets and Therapy » Volume 9

Patients harboring EGFR mutation after primary resistance to crizotinib and response to EGFR-tyrosine kinase inhibitor

Total article views   HTML views PDF downloads Totals
7,928 Dovepress* 7,267+ 1,377 8,644
PubMed Central* 661 250 911
Totals 7,928 1,627 9,555
*Since 8 January 2016
+Since July 2016

View citations on PubMed Central and Google Scholar